malignant peripheral nerve sheath tumor mpnst form cancer connective tissue surrounding nerves given origin behavior classified sarcoma half cases diagnosed people neurofibromatosis lifetime risk mpnst patients neurofibromatosis type mpnst rhabdomyoblastomatous component called malignant triton tumors firstline treatment surgical resection wide margins chemotherapy often radiotherapy done adjuvant andor neoadjuvant treatment depending upon various risk factors symptoms may include soft tissue sarcomas linked within families hypothesized neurofibrosarcoma may genetic although researchers still know exact cause disease evidence supporting hypothesis includes loss heterozygosity chromosome tumor suppressor gene normal population genome neurofibrosarcoma patients mutated increasing probability cancer normal gene regulate cell growth inhibit uncontrollable cell growth healthy population since inactivated neurofibrosarcoma patients much susceptible developing tumors malignant peripheral nerve sheath tumor rare one common frequent soft tissue sarcoma pediatrics population half cases also happen occur along neurofibromatosis type genetic mutation chromosome causes tumors along nervous system lifetime risk patients developing mpnst estimated mpnst general mpnst categorized autosomal dominant disorders means one receives abnormal gene one parents ultimately disorder person chance passing gene offspring pedigree right describes genetic pattern conclusive test patient potential neurofibrosarcoma tumor biopsy taking sample cells directly tumor mris xrays ct scans bone scans aid locating tumor andor possible metastasis malignant peripheral nerve sheath tumors rare type cancer arise soft tissue surrounds nerves type sarcoma malignant peripheral nerve sheath tumors arise nerve plexuses distribute nerves brachial lumbar nerves arise treatment neurofibrosarcoma similar cancers surgery option removal tumor along surrounding tissue may vital patients survival discrete localized tumors surgery often followed radiation therapy excised area reduce chance recurrence patients neurofibrosarcomas extremity tumor vascularized blood supply many nerves going andor around amputation extremity may necessary surgeons argue amputation procedure choice possible due increased chance better quality life otherwise surgeons may opt limbsaving treatment removing less surrounding tissue part bone replaced metal rod grafts radiation also used conjunction surgery especially limb amputated radiation rarely used sole treatment instances oncologist may choose chemotherapy drugs treating patient neurofibrosarcoma usually conjunction surgery patients taking chemotherapy must prepared side effects come chemotherapy treatment hair loss lethargy weakness etc patient response treatment vary based age health tolerance medications therapies metastasis occurs patients commonly lung features associated poor prognosis include large primary tumor cm across high grade disease coexistent neurofibromatosis presence rare tumor type relatively poor prognosis addition mpnsts extremely threatening institutional review treatment chemotherapy mpnst followed cases per live births chemotherapy seem reduce mortality effectiveness questioned although recent approaches molecular biology mpnsts new therapies prognostic factors httpsenwikipediaorgwikimalignantschwannoma